180
Participants
Start Date
April 16, 2025
Primary Completion Date
January 8, 2029
Study Completion Date
January 8, 2029
mRNA-1195
IM injection
Placebo
IM injection
RECRUITING
Quest Research Institute, Farmington Hills
RECRUITING
Washington University School of Medicine Neurology Clinical Unit, St Louis
RECRUITING
Oklahoma Medical Research Foundation (OMRF) MS Center of Excellence, Oklahoma City
RECRUITING
Saturn Research Solutions, Plano
RECRUITING
ANESC Research, El Paso
RECRUITING
Boston Clinical Trials Inc - Internal Medicine, Boston
RECRUITING
University of Texas Southwestern Medical Center, Dallas
RECRUITING
University of the Sunshine Coast Clinical Trials, Birtinya
RECRUITING
North Bristol NHS Trust - Southmead Hospital, Bristol
RECRUITING
Cardiff and Vale University Health Board - University Hospital Wales, Cardiff
RECRUITING
Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh
RECRUITING
NHS Greater Glasgow & Clyde - Institute of Neurological Sciences, Glasgow
RECRUITING
Cambridge Clinical Research Centre, London
RECRUITING
East Kent Hospitals University NHS Foundation Trust, London
RECRUITING
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
RECRUITING
Sheffield Teaching Hospital NHS foundation Trust, Herries Road, Sheffield
ModernaTX, Inc.
INDUSTRY